Impact of large-scale distribution and subsequent use of free nicotine patches on primary care physician interaction

Vladyslav Kushnir, Beth A Sproule, John A Cunningham, Vladyslav Kushnir, Beth A Sproule, John A Cunningham

Abstract

Background: Large-scale distribution efforts of free nicotine replacement therapy (NRT) have been documented to be cost-effective interventions for increasing smoking quit rates. However, despite nearly a dozen studies evaluating their effectiveness, none have examined whether free NRT provision promotes further primary care help-seeking and the impact that it may have on cessation efforts.

Methods: In the context of a randomized controlled trial, a secondary analysis was conducted on 1000 adult regular smokers randomized to be mailed a 5-week supply of nicotine patches or to a no intervention control group. Recipients and users of free nicotine patches at an 8 week follow-up were successfully case matched to controls based on age, gender, baseline level of nicotine dependence and intent to quit (n = 201 per group). Differences in physician interaction between the two groups were evaluated at both 8 week and 6 month follow-ups. The impact of physician interaction on self-reported smoking abstinence at each follow-up was also examined.

Results: Although no differences in physician interaction were noted between groups at the 8 week follow-up, at the 6 month follow-up, nicotine patch users reported greater frequency of discussing smoking with their physician (43.9%), as compared to the control group (30.3%) (p = 0.011). Across both groups, over 90% of those that discussed smoking with a physician were encouraged to quit and approximately 70% were provided with additional support. Separate ANOVAs revealed no significant impact of physician interaction on cessation (p > 0.05), regardless of group or follow-up period, however, at the 6 month follow-up, nicotine patch users who discussed cessation with a physician had made serious quit attempts at significantly greater rates (72.6%), compared to controls (49.1%) (p = 0.007).

Conclusions: Irrespective of group, the majority of smokers in the present study did not discuss cessation with their physician. Recipients and users of nicotine patches however, were more likely to discuss smoking with their physician, suggesting that the provision of free NRT particularly to those who are likely to use it may facilitate opportunities for benefits beyond the direct pharmacological effects of the medication.

Trial registration: clinicaltrials.gov , NCT01429129 . Registered: 2 September 2011.

Keywords: Health professionals; Nicotine replacement therapy; Primary care physicians; Smoking cessation; Tobacco.

Conflict of interest statement

Ethics approval and consent to participate

This research was approved by the Ethics Review Board at the Centre for Addiction and Mental Health (No. 192/2012). All participants provided verbal, over-the-phone consent to participate prior to the start of the baseline interview.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Physician assistance offered between 8 week and 6 month follow-ups. Note: NP, nicotine patch

References

    1. Davis RM. Uniting physicians against smoking: the need for a coordinated national strategy. JAMA. 1988;259:2900–2901. doi: 10.1001/jama.1988.03720190068035.
    1. Leatherdale ST, Shields M. Smoking cessation: intentions, attempts and techniques. Health Rep. 2009;20:31–39.
    1. Stead LF, Bergson G, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2008:CD000165.
    1. Aveyard P, Begh R, Parsons A, West R. Brief opportunistic smoking cessation interventions: a systematic review and meta-analysis to compare advice to quit and offer of assistance. Addiction. 2012;107:1066–1073. doi: 10.1111/j.1360-0443.2011.03770.x.
    1. Fiore M, Jaen C, Baker T, Bailey W, Benowitz N, Curry S, Dorfman S, Froelicher E. U.S. Department of Health and Human Services. 2008. Treating tobacco use and dependence: 2008 update. Clinical practice guidelines.
    1. Cummings SR, Rubin SM, Oster G. The cost-effectiveness of counseling smokers to quit. JAMA. 1989;261:75–79. doi: 10.1001/jama.1989.03420010085038.
    1. Anda RF, Remington PL, Sienko DG, Davis RM. Are physicians advising smokers to quit? The patient's perspective. JAMA. 1987;257:1916–1919. doi: 10.1001/jama.1987.03390140086032.
    1. Quinn VP, Stevens VJ, Hollis JF, Rigotti NA, Solberg LI, Gordon N, Ritzwoller D, Smith KS, Hu W, Zapka J. Tobacco-cessation services and patient satisfaction in nine nonprofit HMOs. Am J Prev Med. 2005;29:77–84. doi: 10.1016/j.amepre.2005.04.006.
    1. Goldstein MG, Niaura R, Willey-Lessne C, DePue J, Eaton C, Rakowski W, Dube C. Physicians counseling smokers. A population-based survey of patients’ perceptions of health care provider-delivered smoking cessation interventions. Arch Intern Med. 1997;157:1313–1319. doi: 10.1001/archinte.1997.00440330047005.
    1. Schnoll RA, Rukstalis M, Wileyto EP, Shields AE. Smoking cessation treatment by primary care physicians: an update and call for training. Am J Prev Med. 2006;31:233–239. doi: 10.1016/j.amepre.2006.05.001.
    1. Goldstein MG, DePue JD, Monroe AD, Lessne CW, Rakowski W, Prokhorov A, Niaura R, Dube CE. A population-based survey of physician smoking cessation counseling practices. Prev Med. 1998;27:720–729. doi: 10.1006/pmed.1998.0350.
    1. Thorndike AN, Rigotti NA, Stafford RS, Singer DE. National patterns in the treatment of smokers by physicians. JAMA. 1998;279:604–608. doi: 10.1001/jama.279.8.604.
    1. Papadakis S, McDonald P, Mullen KA, Reid R, Skulsky K, Pipe A. Strategies to increase the delivery of smoking cessation treatments in primary care settings: a systematic review and meta-analysis. Prev Med. 2010;51:199–213. doi: 10.1016/j.ypmed.2010.06.007.
    1. Twardella D, Brenner H. Effects of practitioner education, practitioner payment and reimbursement of patients’ drug costs on smoking cessation in primary care: a cluster randomised trial. Tob Control. 2007;16:15–21. doi: 10.1136/tc.2006.016253.
    1. Salize HJ, Merkel S, Reinhard I, Twardella D, Mann K, Brenner H. Cost-effective primary care-based strategies to improve smoking cessation: more value for money. Arch Intern Med. 2009;169:230–235. doi: 10.1001/archinternmed.2008.556.
    1. Bush TM, McAfee T, Deprey M, Mahoney L, Fellows JL, McClure J, Cushing C. The impact of a free nicotine patch starter kit on quit rates in a state quit line. Nicotine Tob Res. 2008;10:1511–1516. doi: 10.1080/14622200802323167.
    1. Miller N, Frieden TR, Liu SY, Matte TD, Mostashari F, Deitcher DR, Cummings KM, Chang C, Bauer U, Bassett MT. Effectiveness of a large-scale distribution programme of free nicotine patches: a prospective evaluation. Lancet. 2005;365:1849–1854. doi: 10.1016/S0140-6736(05)66615-9.
    1. Tinkelman D, Wilson SM, Willett J, Sweeney CT. Offering free NRT through a tobacco quitline: impact on utilisation and quit rates. Tob Control. 2007;16(Suppl 1):i42–i46. doi: 10.1136/tc.2007.019919.
    1. Cummings KM, Fix B, Celestino P, Carlin-Menter S, O'Connor R, Hyland A. Reach, efficacy, and cost-effectiveness of free nicotine medication giveaway programs. J Public Health Manag Pract. 2006;12:37–43. doi: 10.1097/00124784-200601000-00009.
    1. Swartz SH, Cowan TM, Klayman JE, Welton MT, Leonard BA. Use and effectiveness of tobacco telephone counseling and nicotine therapy in Maine. Am J Prev Med. 2005;29:288–294. doi: 10.1016/j.amepre.2005.06.015.
    1. Kotz D, Brown J, West R. ‘Real-world’ effectiveness of smoking cessation treatments: a population study. Addiction. 2014;109:491–499. doi: 10.1111/add.12429.
    1. Kotz D, Brown J, West R. Prospective cohort study of the effectiveness of smoking cessation treatments used in the “real world”. Mayo Clin Proc. 2014;89:1360–1367. doi: 10.1016/j.mayocp.2014.07.004.
    1. Cunningham JA, Kushnir V, Selby P, Tyndale RF, Zawertailo L, Leatherdale ST. Effect of mailing nicotine patches to promote tobacco cessation among adult smokers: a randomized clinical trial. JAMA Intern Med. 2016;176:184–190. doi: 10.1001/jamainternmed.2015.7792.
    1. Cunningham JA, Leatherdale ST, Selby PL, Tyndale RF, Zawertailo L, Kushnir V. Randomized controlled trial of mailed nicotine replacement therapy to Canadian smokers: study protocol. BMC Public Health. 2011;11:741. doi: 10.1186/1471-2458-11-741.
    1. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict. 1991;86:1119–1127. doi: 10.1111/j.1360-0443.1991.tb01879.x.
    1. Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot. 1997;12:38–48. doi: 10.4278/0890-1171-12.1.38.
    1. Velicer WF, Prochaska JO, Rossi JS, Snow MG. Assessing outcome in smoking cessation studies. Psychol Bull. 1992;111:23–41. doi: 10.1037/0033-2909.111.1.23.
    1. Niven DJ, Berthiaume LR, Fick GH, Laupland KB. Matched case-control studies: a review of reported statistical methodology. Clin Epidemiol. 2012;4:99–110. doi: 10.2147/CLEP.S30816.
    1. Breslow NE, Day NE. Statistical methods in cancer research; volume 1 - the analysis of case-control studies. Lyon: International Agency for Research on Cancer; 1980.
    1. Fu SS, Burgess D, van Ryn M, Hatsukami DK, Solomon J, Joseph AM. Views on smoking cessation methods in ethnic minority communities: a qualitative investigation. Prev Med. 2007;44:235–240. doi: 10.1016/j.ypmed.2006.11.002.
    1. Levinson AH, Borrayo EA, Espinoza P, Flores ET, Perez-Stable EJ. An exploration of Latino smokers and the use of pharmaceutical aids. Am J Prev Med. 2006;31:167–171. doi: 10.1016/j.amepre.2006.03.022.
    1. Smith AL, Carter SM, Chapman S, Dunlop SM, Freeman B. Why do smokers try to quit without medication or counselling? A qualitative study with ex-smokers. BMJ Open. 2015;5:e007301. doi: 10.1136/bmjopen-2014-007301.
    1. King BA, Dube SR, Babb SD, McAfee TA. Patient-reported recall of smoking cessation interventions from a health professional. Prev Med. 2013;57:715–717. doi: 10.1016/j.ypmed.2013.07.010.
    1. Kruger J, O'Halloran A, Rosenthal AC, Babb SD, Fiore MC. Receipt of evidence-based brief cessation interventions by health professionals and use of cessation assisted treatments among current adult cigarette-only smokers: National Adult Tobacco Survey, 2009–2010. BMC Public Health. 2016;16:141. doi: 10.1186/s12889-016-2798-2.
    1. Reid J, Hammond D, Ruynard V, Burkhalter R. Tobacco use in Canada: Patternsand trends, 2014 edition. In. Waterloo: Properl Centre for Population Health Impact, University of Waterloo; 2014.
    1. Smoking Cessation Services. NICE public health quideline 10. []. Accessed 16 Nov 2016.
    1. Clinical Practice guideline Treating Tobacco Use and Dependence 2008 Update Panel L, and Staff A clinical practice guideline for treating tobacco use and dependence: 2008 update. Ame J Prev Med. 2008;35:158–176. doi: 10.1016/j.amepre.2008.04.009.
    1. Stapleton J, West R, Hajek P, Wheeler J, Vangeli E, Abdi Z, O'Gara C, McRobbie H, Humphrey K, Ali R, et al. Randomized trial of nicotine replacement therapy (NRT), bupropion and NRT plus bupropion for smoking cessation: effectiveness in clinical practice. Addiction. 2013;108:2193–2201. doi: 10.1111/add.12304.
    1. Chang PH, Chiang CH, Ho WC, Wu PZ, Tsai JS, Guo FR. Combination therapy of varenicline with nicotine replacement therapy is better than varenicline alone: a systematic review and meta-analysis of randomized controlled trials. BMC Public Health. 2015;15:689. doi: 10.1186/s12889-015-2055-0.
    1. Hajek P, Smith KM, Dhanji AR, McRobbie H. Is a combination of varenicline and nicotine patch more effective in helping smokers quit than varenicline alone? A randomised controlled trial. BMC Med. 2013;11:140. doi: 10.1186/1741-7015-11-140.
    1. Ramon JM, Morchon S, Baena A, Masuet-Aumatell C. Combining varenicline and nicotine patches: a randomized controlled trial study in smoking cessation. BMC Med. 2014;12:172. doi: 10.1186/s12916-014-0172-8.
    1. Skevington SM, Lotfy M, O'Connell KA. The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res. 2004;13:299–310. doi: 10.1023/B:QURE.0000018486.91360.00.

Source: PubMed

3
Abonnieren